Skip to content

Clinical trials

Carcinoma, Squamous Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20081
20111
20131
20153
20161
20172
20181
20192
20203
20222
20231
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated8
Recruiting6
Active, not recruiting3
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Rain Oncology Inc2
3B Pharmaceuticals GmbH1
AVEO Pharmaceuticals, Inc.1
Amgen1
Ariad Pharmaceuticals1
AstraZeneca1
Bicara Therapeutics1
Blaze Bioscience Australia Pty Ltd1
Clinuvel Pharmaceuticals Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell27
Squamous Cell Carcinoma of Head and Neck10
Carcinoma, Non-Small-Cell Lung9
Melanoma5
Carcinoma, Large Cell4
Head and Neck Neoplasms4
Adenocarcinoma3
Carcinoma3
Colorectal Neoplasms3
Neoplasm Metastasis3

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.